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Abstract
Background:  The  var  multigene family encodes PfEMP1, which are expressed on the surface of infected
erythrocytes and bind to various host endothelial receptors. Antigenic variation of PfEMP1 plays a key role in
malaria pathogenesis, a process partially controlled at the level of var gene transcription. Transcriptional levels,
throughout the intra-erythrocytic cycle, of 59 var genes of the NF54 clone were measured simultaneously by
quantitative real-time PCR. The timing of var transcript abundance, the number of genes transcribed and whether
transcripts were correctly spliced for protein expression were determined. Two parasite populations were
studied; an unselected population of NF54 and a selected population, NF54VAR2CSA, to compare both the
transcription of var2csa and the expression pattern of the corresponding protein.
Methods: Synchronized parasites were harvested at different time points along the 48 hours intra-erythrocytic
cycle for extraction of RNA and for analysis of expression of variant surface antigens by flow cytometry. Total
RNA from each parasite sample was extracted and cDNA synthesized. Quantitative real-time PCR was
performed using gene-specific primers for all var genes. Samples for flow cytometry were labelled with rabbit IgG
targeting DBL5ε of VAR2CSA and serum IgG from malaria-exposed men and pregnant women.
Results: var transcripts were detected at all time points of the intra-erythrocytic cycle by quantitative real-time
PCR, although transcription peaked in ring-stage parasites. There was no difference in the timing of appearance
of group A, B or C transcripts, and dominant and subdominant var transcripts appeared to be correctly spliced
at all time points. VAR2CSA appeared on the surface of infected erythrocytes 16 hours after invasion, consistent
with previous studies of other PfEMP1. Transcription of the pseudogene var1csa could not be detected in
NF54VAR2CSA cells.
Conclusion: The optimal sampling point for analysis of var transcripts using quantitative real-time PCR is the ring-
stage, which is encouraging for the analysis of fresh clinical isolates. The data presented here indicate that there
is no promiscuous transcription of var genes at the individual cell level and that it is possible to correlate dominant
transcripts with adhesion phenotype and clinical markers of malaria severity.
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Background
Malaria caused by Plasmodium falciparum is a global health
problem and the majority of severe clinical cases are
found among young children and pregnant women. Plas-
modium falciparum erythrocyte membrane protein 1
(PfEMP1) is a group of variant surface antigens (VSA)
expressed on the surface of infected erythrocytes, thus ena-
bling the parasite to sequester in various endothelial tis-
sues of the host and avoid clearance in the spleen [1,2].
Several receptors have been identified as mediators of the
sequestration, e.g. CD36 [3], thrombospondin [4] and
ICAM-1, associated with cerebral malaria [5] and chon-
droitin sulfate A (CSA), the main receptor in the placenta
and associated with pregnancy-associated malaria (PAM)
[6]. PfEMP1 are encoded by the highly diverse var gene
family and each parasite genome harbours ~60 of these
genes [7-9]. The var gene repertoire of the 3D7 parasite
[10] can be sub-grouped into three major groups (A, B
and C), two intermediate groups (B/A and B/C), and the
var1csa  and  var2csa  sub-families based on promoter
regions and chromosomal locations [11,12].
VSA appear to be the main target of antibodies conferring
protective immunity against malaria [13-17]. However,
antigenic diversity and var  gene switching have made
unambiguous identification of the PfEMP1 molecules
that are responsible for specific adhesion phenotypes dif-
ficult. A quantitative real-time PCR (Q-RT PCR) method
was developed to measure the amount of mRNA being
transcribed from 59 different NF54/3D7 var genes simul-
taneously [18]. Using this approach, a particular PfEMP1,
VAR2CSA, was identified as the parasite ligand likely to be
responsible for CSA binding in the placenta [18,19]. In
another study using the same method, the group A var
genes of 3D7 were associated with severe malaria [20,21].
However, correlating expression of var genes to the phe-
notype of a parasite population can yield equivocal
results, and studies on var gene transcription have given
conflicting results regarding both the number of var genes
being transcribed and the size of these transcripts. Two
reverse transcription (RT)-PCR studies suggested that
most or all var genes are transcribed in ring-stage parasites,
whereas in mature trophozoites all but one var gene was
silenced. Only the var  gene actively transcribed in late
stages would then be translated into protein to confer the
phenotype [22,23]. Other studies have proposed that
multiple full-length var  transcripts are present in ring-
stage parasites but not in mature stages, with the excep-
tion of the var1csa gene which was detectable in both tro-
phozoites and later stages [24,25]. A third group of studies
detected multiple full-length transcripts in ring-stage and
mature trophozoite parasites in both clonal populations
[26] and in single cells [27].
To investigate var  gene mRNA levels in general, and
var2csa levels in particular, their abundance and quality
were determined in two phenotypically different NF54-
derived lines using Q-RT PCR throughout the intra-eryth-
rocytic developmental cycle.
Methods
In vitro culture
The NF54 clone of P. falciparum was cultured as described
by Trager and Jensen with modifications [28]. In brief,
parasites were maintained in culture using 5% haemat-
ocrit of human group O+ blood in parasite medium con-
sisting of RPMI1640 HEPES medium, supplemented with
25 mmol/L sodium bicarbonate (Sigma-Aldrich), 0.125
g/l gentamicin (Invitrogen), and 0.125 g/l Albumax II
(Invitrogen). Culture flasks were maintained in a 37°C
incubator and gassed with a mixture of 2% oxygen and
5% carbon dioxide in nitrogen. The parasite lines were
confirmed to be monoclonal and of same genotype as
3D7, using nested GLURP, and MSP2-specific primers in
a single PCR step.
Selection of VAR2CSA-expressing parasites
The NF54 parasite isolate was repeatedly selected using
VAR2CSA-specific antibodies. Briefly, late-stage tropho-
zoites were obtained by gelatin purification and washed
twice in RPMI1640. The infected erythrocytes were then
incubated for 0.5 hour at 37°C with VAR2CSA-DBL5ε-
specific rabbit antiserum and washed three times with
medium to remove unbound antibodies. Infected eryth-
rocytes expressing VAR2CSA were isolated by the use of
protein G-coupled magnetic beads (Dynal, Invitrogen) on
a MACS magnet (Miltenyi Biotec). The suspension of
infected erythrocytes and beads was washed three times
and added to a culture flask with 4% haematocrit of unin-
fected erythrocytes in 5 ml culture medium. After 24
hours, the beads were removed by magnetic separation.
This was repeated until parasites specifically expressed
VAR2CSA on the surface. Expression of the VSAPAM pheno-
type was confirmed by specific binding of parasites to CSA
in static binding assays and exclusive recognition of the
surface of the infected erythrocytes by antibodies from
women exposed to P. falciparum during pregnancy. This
was done by flow cytometry using a panel of serum sam-
ples from P. falciparum-exposed men and women and
non-exposed Danes as described [29,30].
NF54 and NF54VAR2CSA cultures were loosely synchro-
nized by gelatine purification of late-stage trophozoites
and schizonts. After 48 hours of culture, late-stage tropho-
zoites and schizonts were further enriched on a MACS col-
umn to exclude any remaining ring stages, as previously
described [31]. This resulted in a synchronous population
of parasites with more than 99% late-stage trophozoites
and schizonts. Timing of parasite reinvasion was deter-Malaria Journal 2007, 6:78 http://www.malariajournal.com/content/6/1/78
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mined by counting the percentage of ring-stage parasites
of 300 infected erythrocytes on thin smears stained by
Giemsa (Figure 2). For RNA extractions, each parasite line
was cultured in 26 different culture flasks at 1% hemat-
ocrit (50 μl packed red blood cells) with ~10% parasitae-
mia after reinvasion. This was done to minimize handling
time of the parasite cultures at other time points than dur-
ing harvesting. The culture was centrifuged and 1 ml of
Trizol (Invitrogen) was added to the pellet to preserve
RNA. For flow cytometry assays eight different culture
flasks were prepared for each isolate. Since separation of
ring stages from uninfected erythrocytes is difficult, these
cultures were prepared at 0.25% haematocrit with approx-
imately 25% parasitaemia observed after reinvasion to
allow for direct staining and flow cytometric analysis.
Flow cytometry
Flow cytometry was used to assess the timing of VAR2CSA
surface expression by each line as described [29,30]. Aliq-
uots of the parasite culture corresponding to 2 × 105
infected erythrocytes were labelled by ethidium bromide
(to allow exclusion of remaining uninfected erythrocytes).
Pools of human sera and rabbit VAR2CSA-specific serum
were used for IgG surface-staining of infected erythrocytes.
Infected erythrocytes were sequentially exposed to 5 μl
pooled human serum, and 1 μl goat anti-human IgG (Vec-
tor) in a total volume of 100 μl. For surface staining by
rabbit VAR2CSA DBL5ε -specific IgG, samples were
sequentially exposed to 20 μl rabbit serum pre-absorbed
against uninfected erythrocytes, 1 μl biotinylated sheep
anti-rabbit IgG (The Binding Site) and 0.5 μl streptavidin-
FITC (BD Pharmingen). All incubations were performed
in a total volume of 100 μl PBS with 2% FCS for 30 min.
Samples were washed twice with 3 ml PBS with 2% FCS in
between each incubation. Data from a minimum of 5,000
infected erythrocytes were acquired using a FACScan
instrument (BD Biosciences). A batch of uninfected eryth-
rocytes was analysed to exclude IgG binding to erythrocyte
antigens. All samples relating to a particular time point
were stained and processed immediately after removal
from the 37°C incubator.
RNA purification and cDNA synthesis
Synchronized infected erythrocytes were harvested every 2
hours throughout the intra-erythrocytic life cycle for
extraction of total RNA and cDNA synthesis as described
elsewhere [18]. A representative subset of samples that
described the profile of the transcript abundances was fur-
ther analysed by Q-RT PCR. In brief, 50 μl of packed eryth-
rocytes with ~10% parasitaemia was dissolved in 1 ml of
Trizol (Invitrogen) and RNA was prepared according to
the manufacturer's instruction. RNA pellets were dis-
solved in 10 μl of RNase-free water and treated with DNa-
seI (Sigma-Aldrich) for 25 min at room temperature,
Table 1: Specific gene primers used for Q-RT PCR. Primers used to specifically amplify var genes, a pseudogene and control genes in 
Q-RT PCR, in addition to primer sets designed by Salanti et al. [18]. Primers from Salanti et al. that were used in this study (but not 
shown in table): no. 4–12, 15, 17–23, 25–28, 30, 34–39, 41, 43, 45, 46, 49–55, 91–96, and 97.
Primer set Forward primer Reverse primer Target gene
1 new TAAATTGCTCAATCGCGAAG CATCGTCATCATCGTCATCA PFA0005w
16 AAAGCCACTAGCGAGGGTAA TGTTTTTGCCCACTCCTGTA PFL1955w
24 AGGACAACACGGATGAGACA AGCAGTGTTGTCGCCATTAG PFC0005w
32 ACCTAATGGCGAAAACCAAG ACACTTGCCTTCATCCACTG PFD1000c
44 new CCTACACTCACCTCCCCCTA ACACTCACACGCCTCATCAT PFF1580c
58 new ACAACAATTTCGCAAGCAAG TTCCTCTGCCTCCTCTTCAT PFI1830c
66 CCTAAAAAGGACGCAGAAGG CCAGCAACACTACCACCAGT PF08_0107
67 AAGGGAAGATTGGTGGACAG AGGGGGATCAGTATCACGTC PFF0020c
90a TCAATTTGATAAAGTGGAACAATTC GCGTTGTTTAAAGCTCCTGA PF07_0073
98 ATGGTGGCAAACTTGTGAGA TCCAATTGGTCTCCTTGACA PF08_0140
99 AGGGAGCATCAGGTGGTAGT GCTGTGCATGCTTTTTCATT MAL7P1.50
100 GATCAAAAGAGGCGGAGAAG TTCCAATTGGGGAATTTTTC PFI0005w
101 CAAGAGACACAACCGGAAGA CACTTCCAATTGGGGAATTT PFA0765c
498/499 AATCAGAAAAGTGTAATTGCAGGAG TTTACTATCATCACTGACACGCATT MAL7P1.212
500/501 GTCCTCTATGTGGAGTGAAAAAGAA AGTACCGTTATCTGGGTTTATAGGC MAL8P1.220
392/393b AAACGAAAGCGAAGCAGAAT CACCTTCACTCCTTGCCATA PFF0005c
334/335 AGCCCAATCGGAAGGTAAGT TTCATAGCTTCTAGCGCCTT PFL0030c
UTR var2csa CACGACATTAACAATACATGCAGA CATTGCATTCACAGACATTGG PFL0030c
390/391c AATAATACCAGTGACATTCTGCAAAA ACACGTAAAAGGTCCACAGGTG PFL0030c
535/536c CCAGCAGGACCAGCAACAGATAGTGGC CCACTTCTATATGGTATGTACCTATTTTTG PFL0935c
496/497c AATCACTTCCGCAACCCCCACG CTGAAAAGGTCCACACGAGG PFD0615c
MSP1 ACAACTGAAGATGGGGGTCA TTTTGGTGGTGATGGTTGTG PFI1475w
a. Endogeneous control gene, seryl-tRNA synthetase.
b. Pseudogene.
c. Primers designed to target flanking regions of the intron (cross-intron primers).Malaria Journal 2007, 6:78 http://www.malariajournal.com/content/6/1/78
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followed by 10 min heat inactivation at 65°C. All RNA
samples were subsequently tested in real-time PCR for
contamination with genomic DNA using a primer set for
the seryl-tRNA synthetase gene (Table 1). DNA-free RNA
samples were used for synthesis of cDNA by reverse tran-
scriptase (Superscript II, Invitrogen) and random hexamer
primers as described by the manufacturer. The cDNA con-
tent was confirmed by real-time PCR using primers for the
seryl-tRNA synthetase gene.
Primer design
Transcription of all the var genes was determined using
primers originally published by Salanti et al. [18],
although some have since been redesigned (Table 1).
Table 1 also contains primers designed to target new var
genes identified in the P. falciparum genome database [32]
and primers for additional genes used as controls (msp1 –
PFI1475w and seryl-tRNA synthetase – PF07_0073). All
primers were initially tested on genomic DNA to deter-
mine the 'amplification efficiency' compared to the
amplification of the internal control, seryl-tRNA synthetase.
Primer pairs that varied more than two Ct values from the
Ct value of the internal control were redesigned. Primers
for detecting spliced var transcripts were designed to target
the flanking regions of the intron (cross-intron primers).
The 'amplification efficiency' of these cross-intron primers
was not determined. However, all cross-intron primers
were tested on genomic DNA in conventional PCR with
increased elongation time and the PCR products were
fractionated by agarose gel electrophoresis. The cross-
intron products amplified from cDNA by Q-RT PCR were
also fractionated by agarose gel electrophoresis.
Quantitative real-time PCR
All Q-RT PCR measurements were performed using the
Rotorgene RG-3000 system (Corbett Research). Reactions
were prepared in volumes of 20 μl using QuantiTect SYBR
Green PCR master mix (QIAGEN) and a primer concen-
tration of 1 μM. The following PCR cycling conditions
were used: initial heat activation step at 95°C for 15 min,
followed by 40 cycles of 95°C for 30 s, 55°C for 30 s and
68°C for 40 s with a final extension at 68°C for 40 s. The
amplification specificity for each primer pair was deter-
mined by melting-curve analysis of each PCR product.
Quantitative analysis
Gene specific standard curves were generated by deter-
mining the 'amplification efficiency' relative to the single
copy endogeneous control gene (seryl-tRNA synthetase),
based on real-time measurements of 10-fold dilutions of
genomic DNA. Transcript abundance was determined
according to the ΔCt (cycle threshold) method, in which
the Ct value for each specific gene was compared with that
of the endogeneous control, and by calculating the rela-
tive copy number, based on the specific standard curves
for each gene. Standard curves for the cross-intron primers
were not generated.
Results
Transcripts of var genes were detected throughout the 
intra-erythrocytic life cycle
Using Q-RT PCR the var transcriptome pattern throughout
the intra-erythrocytic life cycle was investigated for two
parasite cultures, NF54 and NF54VAR2CSA. Figure 1A
and 1B show the transcript abundance of 59 full-length
var genes and two var pseudogenes in NF54/3D7 as rela-
tive copy numbers normalized to the internal control,
seryl-tRNA synthetase (PF07_0073). The percentage of ring-
stage parasites was determined by Giemsa staining (Figure
2), in addition to measurements of msp1  (PFI1475w)
transcript abundance to control for stage specificity of
each parasite population (Figure 1A and 1B). For both cul-
tures there was a clear peak in transcript abundance at ring
stage, ~5–25 hours after invasion. Figure 1C shows the
transcript abundance of each full-length var gene relative
to total number of var transcripts, in which the proportion
of the most abundant transcript was higher at ring stage
compared to the schizont stage.
The most abundant var transcript in NF54 ring-stage par-
asites was PFL0935c (Figure 1A and 1C), which in the 3D7
genome is a centromeric var gene on chromosome 12 with
a group B 5' UTR promoter according to the grouping of
3D7  var genes [10-12]. Two additional var  genes were
transcribed at high levels in NF54, PFL1960w (group C,
localized on chromosome 12 in the 3D7 genome) and
PF08_0106 (group B/C, on chromosome 8). By contrast,
NF54VAR2CSA represents a highly homogeneous popula-
tion, which transcribes almost solely var2csa (PFL0030c,
on chromosome 12). All other var genes were transcribed
at low levels or below the detection level (Figure 1B).
Three primer sets targeting DBL2, DBL4, and the 5' UTR of
var2csa, were used and the results obtained with these
primers were tightly correlated (Figure 1B). Transcripts of
var2csa were also detected in the unselected NF54 at low
levels, similar to those of the less abundant var mRNA
The transcriptional time profile of var2csa  appeared
slightly different from the other var genes. This is most evi-
dent in Figure 3 showing relative copy numbers of the
most abundant var transcript as well as total var transcripts
in both populations. The transcript abundance peak of
var2csa in both parasite populations emerges slightly ear-
lier in the ring stage of the parasite development and also
declines faster than for the other var genes (Figure 1A and
3). In addition, the broad transcript abundance peak in
NF54 seems to consist of two waves, a pattern which was
observed for all the var genes (Figure 1A and 3). No differ-
ences between the various var gene groups (A, B and C)Malaria Journal 2007, 6:78 http://www.malariajournal.com/content/6/1/78
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were detected regarding appearance and disappearance of
transcripts.
The transcript abundance of two truncated sub-telomeric
var pseudogenes of NF54/3D7, var1csa (PFE1640w, on
chromosome 5, lacks intron and exon II) and PFF0005c
(group A pseudogene, on chromosome 6, truncated in
DBL1α), was also determined. var1csa, which has been
found to be constitutively transcribed in many parasites
irrespective of binding phenotype [25], was constitutively
transcribed at high levels in NF54 but barely detected in
NF54VAR2CSA (Figure 1A and 1B, respectively). The
more recently discovered var pseudogene, PFF0005c, was
detected at a few time points at very low levels in both iso-
lates.
Dominant and subdominant var genes are transcribed as 
spliced mRNA throughout the intra-erythrocytic life cycle
To investigate whether var transcripts are correctly spliced
throughout the intra-erythrocytic life cycle, specific cross-
intron primers were designed (Table 1) for the dominant
(most abundant) gene in each isolate (PFL0935c and
var2csa) and a variant that was subdominant (less abun-
dant) in both parasite populations (PFD0615c, group C,
on chromosome 4). The transcript abundance profiles
measured by the cross-intron primers targeting the domi-
Transcriptional profiles of NF54/3D7 var genes in two phenotypically different parasites Figure 1
Transcriptional profiles of NF54/3D7 var genes in two phenotypically different parasites. Quantification of all the 
var transcripts normalized against seryl-tRNA synthetase and shown as log10(relative copy number) in (A) and (B) and as pie 
charts in (C) at different time points during the intra-erythrocytic life cycle of NF54 and NF54VAR2CSA. (C) shows only 
expression of full-length var genes. (A) and (B):blue – msp1 (was used for monitoring the different stages), green – PFL0935c 
(dominant transcript in NF54), grey – var1csa, red diamonds – var2csa (DBL4 primers), red circles – var2csa (DBL2 primers), 
red rectangles – var2csa (5' UTR primers). (C): light green – PFL0935c, red – var2csa (DBL2 primers). pi – post invasion
msp1
PFL0935c
var1csa
var2csa (DBL4 primers)
var2csa (DBL2 primers)
var2csa (5’ UTR primers)
AB
C
44 h 26 h 16 h 2 h -4  h 3 4  h
NF54
Hours pi
NF54VAR2CSAMalaria Journal 2007, 6:78 http://www.malariajournal.com/content/6/1/78
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nant and subdominant genes were similar to the profiles
given by the corresponding exon I primers. This indicates
both that the two sets of primers were recognizing the
same transcript and that most, if not all, detectable tran-
scripts were already spliced (Figure 4). The difference in
ΔCt value between the primer sets for PFL0935c (Figure
4A) was most likely due to differential primer bias.
Timing of VAR2CSA expression on the surface of 
NF54VAR2CSA
Parasites from infected placentae and CSA-selected late-
stage parasites are recognized by human immune sera in
a sex-specific manner. This was also the case for
NF54VAR2CSA (Figure 5B). As expected, there was no dif-
ference in the recognition of unselected NF54 by female
and male sera (Figure 5A). The flow cytometry data con-
firmed published findings that VAR2CSA, like other
PfEMP1, appears on the surface of infected erythrocytes
several hours after the first detection of var transcription
(Figure 1B and 5B). Surface-exposed VAR2CSA was
detected by VAR2CSA-specific rabbit antibodies and
female serum from a malaria endemic area about 18
hours after invasion, and the amount of PfEMP1 reached
a plateau which seemed to remain constant throughout
the later stages. Male immune sera, on the other hand,
showed the same lack of recognition of NF54VAR2CSA as
was seen in unselected NF54.
Discussion
Transcript levels of var genes were analyzed throughout
asexual parasite development using an improved version
of the Q-RT PCR method originally published by Salanti
et al. [18]. Primer pair coverage was extended to optimize
quantitative measurement of mRNA transcribed from 59
full-length var genes and two pseudogenes in the NF54/
3D7 genome. Two phenotypically distinct NF54-derived
lines, NF54 (unselected) and NF54VAR2CSA (selected for
VAR2CSA expression) showed abundance peaks of domi-
nant and subdominant var  transcripts at ring stage,
although the relative abundance of the dominant tran-
script in each population was higher in ring stage and
early trophozoites than in schizonts. This can be
explained by the increased uncertainty of measurement
when transcript abundance is very low.
Unselected NF54 parasites are clearly a mixture of sub-
populations expressing different var  genes (Figure 1).
However, after repeated selection, the var2csa gene has
become the overwhelmingly dominant transcript and
constitutes >98% of all detected var transcripts. This pat-
tern of exclusive expression of the var2csa gene (Figure
1C) supports the general model of mutually exclusive
transcription of var genes. Such a general model was pro-
posed after experiments showed that exclusive transcrip-
tion of activated group B and C 5' UTR promoters
occurred following transfection [33,34]. It is likely that a
significant proportion of the unselected ring-stage NF54 is
exclusively expressing the dominant group B var  tran-
script. However, this is not as apparent in this line as in
the NF54VAR2CSA due to the heterogeneity of this unse-
lected population. While it remains to be proven that var
transcription in circulating parasites in the bloodstream
can always be correlated to the binding phenotype of the
corresponding trophozoite population, this study sup-
ports such a conclusion. Another recent study has shown
that the genotypes of the circulating ring-stage parasites
represent the types of the mature parasites sequestering in
most tissues [35].
Improved quantification of transcript abundances of each
var gene obtained by Q-RT PCR and use of cross-intron
primers also support a revision of the view that var tran-
scripts are exclusively restricted to the ring stage and that
there is promiscuous transcription of many var genes in
ring-stage parasites [24,36]. New data, reported here and
in other recent publications [37], indicate that the so-
called 'loose' transcription of several var transcripts per
infected erythrocyte results from cross-hybridization arte-
facts and the background of gene expression from minor-
ity populations in cultures which are not expressing the
dominant, selected var gene.
Truncated or unspliced transcripts in parasites have also
been reported [8,38]. In this study, cross-intron primers
for three different var genes, var2csa (PFL0030c), a group
B gene (PFL0935c) and a group C gene (PFD0615c) all
showed splicing of exon I to exon II in both the unselected
Percentage of ring-stage parasites in the synchronized popu- lations Figure 2
Percentage of ring-stage parasites in the synchro-
nized populations. The percentage of ring-stage parasites 
in the NF54 and NF54VAR2CSA population was determined 
by Giemsa staining for different time points along the cycle.Malaria Journal 2007, 6:78 http://www.malariajournal.com/content/6/1/78
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and VAR2CSA-selected NF54 parasites throughout the
whole cycle, indicating that these var genes are normally
expressed as correctly spliced transcripts (Figure 4). The
fact that the transcription levels of the four different
var2csa-specific primers were tightly correlated further
indicates that the transcripts are not only correctly spliced
but also probably full-length at all stages. This is contrary
to a conclusion drawn in an earlier study in which a dif-
ference between the levels of transcription detected by
cross-intron primers and exon I primers of some var genes
using Q-RT PCR were reported [38]. This discrepancy
could be due to the 'amplification bias' of the cross-intron
primers, and the difficulties of designing unique primers
targeting the exon II. However it is worth noting that pro-
miscuous transcription in any form is incompatible with
transfection experiments showing the exclusive expres-
sion of a single var gene regulated at a pre-transcriptional
level [33,34,39,40].
It has also been suggested that there is a differential repres-
sion of the various var gene groups based on their promot-
ers [41]. The group B genes (subtelomeric) were shown to
be transcribed 0–10 hours after invasion, and turned off
when the parasites reached later stages, whereas the group
C (chromosome-central) transcripts were still detected 4–
8 hours later than the subtelomeric genes. This differential
transcription pattern was not seen here. All var  genes
within group A, B or C in the unselected NF54 population
showed the same abundance profile regardless of pro-
moter.
Both var1csa and var2csa have unique promoters (group D
and E respectively, [11,12], and both these genes showed
distinctive expression profiles. var1csa  transcription
remains anomalous and poorly understood. var1csa was
constitutively transcribed in the unselected NF54 line, a
result reported previously for several P. falciparum isolates,
regardless of their receptor binding phenotype [25,38,42].
However, var1csa transcription was not detected in any
stages in NF54VAR2CSA. This observation is most simply
explained by a var1csa-expressing subpopulation of NF54
having been removed by VAR2CSA selection. This inter-
pretation further entails that only one var gene is tran-
scribed per infected erythrocyte and the var1csa gene is
restrained from transcription by the silencing mecha-
nisms operating on all var genes that is imposed when
another var gene, in this case var2csa, is expressed.
The essentially exclusive expression of a single var gene
that is observed in the NF54VAR2CSA parasites, where
var2csa constitutes 98% of total var gene abundance, has
previously only been observed in P. falciparum cultures
transfected with drug-selectable marker genes [33,34]. In
these experiments, transgenic parasite lines use a var pro-
moter to drive expression of a drug resistance gene rather
than a PfEMP1 protein. Drug selection followed by clon-
ing and analysis of resistant lines indicates that the trans-
fected recombinant promoter is activated in these lines
and that all other var promoters are silenced. There is dis-
agreement as to whether a single active var promoter is
sufficient to silence all other promoters [34] or whether
the system of allelic exclusion requires both the 5' var pro-
moter and a promoter located downstream in the var gene
intron to interact in some way to silence transcription
[43,44].
Transcription of var1csa in the unselected NF54 presuma-
bly results from a subpopulation of parasites in which
other var  genes are silenced. The relatively constitutive
transcription of var1csa may result from a dysfunction of
the transcriptional regulation related to the cell cycle. As
var1csa has an upstream promoter but is truncated at exon
I, it can be hypothesized that its 5' UTR promoter, as pre-
viously demonstrated [34] is needed for exclusive tran-
scription of a single var gene whereas the intron/exon II/
3' UTR is needed for the observed wave shaped transcrip-
tional regulation throughout the cell cycle. Yet, the abun-
dance profile of var1csa  during the complete intra-
Total number of var transcripts in NF54 and NF54VAR2CSA Figure 3
Total number of var transcripts in NF54 and 
NF54VAR2CSA. Total var transcription is shown as rela-
tive copy number for both NF54 and NF54VAR2CSA. Total 
var transcription of both populations corresponds to the 
expression of the most abundant transcript, PFL0935c and 
var2csa (PFL0030c), respectively. The most striking differ-
ence in transcription is the slightly earlier distinctive peak for 
var2csa (PFL0030c) in NF54VAR2CSA compared to the 
broader wave-like appearance of var transcription in NF54. 
All measurements at the different time points were normal-
ized against seryl-tRNA synthetase.Malaria Journal 2007, 6:78 http://www.malariajournal.com/content/6/1/78
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erythrocytic cycle in other isolates than 3D7 and NF54
remains unclear, and more studies are needed to elucidate
the role of this var gene. Furthermore, it is not known
whether the apparent lack of other pseudogene-transcrib-
ing subpopulations, here represented by PFF0005c, can be
related to the difference in the 5' UTR promoter.
var2csa had a pattern of changes in mRNA abundance sim-
ilar to that of the other var genes being transcribed in the
unselected NF54 line. However, the abundance profile
indicated that its transcription peaks earlier in the ring
stage than the other var genes. Since the timing of the cycle
of both lines were tightly correlated according to the
Giemsa stain assessment, this observation is probably not
due to major differences in synchronization. The protein
expression of VAR2CSA did not seem to diverge from ear-
lier reports showing that PfEMP1 molecules appear to be
present on the infected erythrocyte membrane around
16–18 hours after invasion [45-47]. As expected, the rec-
ognition pattern of NF54VAR2CSA by rabbit antibodies
raised against recombinant-produced DBL5ε of VAR2CSA
was correlated with the recognition of the immune sera of
malaria-exposed multi-gravidae women from a malaria
endemic area.
Conclusion
var  transcription can be measured by Q-RT PCR at all
stages throughout the intra-erythrocytic life cycle. How-
ever, to identify the dominant transcript in a parasite pop-
ulation it is critical to perform the analysis on ring-stage
parasites when transcript levels peak. The findings that a
highly homogeneous parasite population transcribes
essentially one var gene at all time points and that the
var2csa gene, a group B var gene and a group C var gene are
all expressed as correctly spliced transcripts at all intra-
erythrocytic stages suggest that previous reports of promis-
cuous transcription of many var genes in a single parasite
might represent experimental artefacts resulting from the
presence of heterogeneous parasite populations.
Authors' contributions
MD carried out the RNA extractions, cDNA synthesis and
all the Q-RT PCR experiments, analysed the data and
wrote the manuscript. TL participated in the design of the
study, helped with primer design, the Q-RT PCR and to
draft the manuscript. AS contributed to the study design
and helped to draft the manuscript. LH, DEA and TGT
helped to finalise the manuscript. MAN participated in
the study design, carried out all the parasite work and flow
Both dominant and subdominant var genes seem to be correctly spliced throughout the whole intra-erythrocytic life cycle Figure 4
Both dominant and subdominant var genes seem to be correctly spliced throughout the whole intra-erythro-
cytic life cycle. Transcript abundance measured by cross-intron primers and exon I primers for the dominant and two sub-
dominant var genes are shown as ΔCt values for (A) NF54 and (B) NF54VAR2CSA.
ABMalaria Journal 2007, 6:78 http://www.malariajournal.com/content/6/1/78
Page 9 of 11
(page number not for citation purposes)
cytometry experiments and helped to finalise the manu-
script. All authors read and approved the final manu-
script.
Acknowledgements
MD is supported by a PhD studentship from the Danish Research Council 
for Development Research (RUF). AS is supported by a postdoctoral grant 
from the Danish Medical Research Council (SSVF). MAN is supported by a 
postdoctoral grant from Hovedstadens Sygehusfaellesskab.
References
1. David PH, Hommel M, Miller LH, Udeinya IJ, Oligino LD: Parasite
sequestration in Plasmodium falciparum malaria: spleen and
antibody modulation of cytoadherence of infected erythro-
cytes.  Proc Natl Acad Sci USA 1983, 80:5075-5079.
2. Howard RJ, Barnwell JW: Roles of surface antigens on malaria-
infected red blood cells in evasion of immunity.  Contemp Top
Immunobiol 1984, 12:127-200.
3. Ockenhouse CF, Tandon NN, Magowan C, Jamieson GA, Chulay JD:
Identification of a platelet membrane glycoprotein as a falci-
parum  malaria sequestration receptor.  Science 1989,
243:1469-1471.
4. Roberts DD, Sherwood JA, Spitalnik SL, Panton LJ, Howard RJ, Dixit
VM, Frazier WA, Miller LH, Ginsburg V: Thrombospondin binds
falciparum malaria parasitized erythrocytes and may medi-
ate cytoadherence.  Nature 1985, 318:64-66.
5. Berendt AR, Simmons DL, Tansey J, Newbold CI, Marsh K: Intercel-
lular adhesion molecule-1 is an endothelial cell adhesion
receptor for Plasmodium falciparum.  Nature 1989, 341:57-59.
6. Fried M, Duffy PE: Adherence of Plasmodium falciparum to
chondroitin sulfate A in the human placenta.  Science 1996,
272:1502-1504.
7. Baruch DI, Pasloske BL, Singh HB, Bi XH, Ma XC, Feldman M, Taras-
chi TF, Howard RJ: Cloning the Plasmodium falciparum gene
encoding PfEMP1, a malarial variant antigen and adherence
receptor on the surface of parasitized human erythrocytes.
Cell 1995, 82:77-87.
8. Su XZ, Heatwole VM, Wertheimer SP, Guinet F, Herrfeldt JA, Peter-
son DS, Ravetch JA, Wellems TE: The large diverse gene family
var  encodes proteins involved in cytoadherence and anti-
genic variation of Plasmodium falciparum-infected erythro-
cytes.  Cell 1995, 82:89-100.
9. Smith JD, Chitnis CE, Craig AG, Roberts DJ, Hudson-Taylor DE,
Peterson DS, Pinches R, Newbold CI, Miller LH: Switches in
expression of Plasmodium falciparum var genes correlate with
changes in antigenic and cytoadherent phenotypes of
infected erythrocytes.  Cell 1995, 82:101-110.
10. Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, Carl-
ton JM, Pain A, Nelson KE, Bowman S, Paulsen IT, James K, Eisen JA,
Timing of VAR2CSA surface expression Figure 5
Timing of VAR2CSA surface expression. Surface staining of infected erythrocytes selected with VAR2CSA-specific rabbit 
antibodies, NF54VAR2CSA, and the unselected control, NF54. The median of FITC fluorescence as measured by flow cytome-
try is shown for each serum sample. Pools of human sera from P. falciparum exposed females and males, and unexposed Danes 
(DK-pool) were used as primary antibodies. VAR2CSA expression was confirmed by staining with VAR2CSA DBL5ε-specific 
rabbit antibodies and irrelevant rabbit immune serum was used as negative control. Samples were processed and run simulta-
neously at individual time points.
ABMalaria Journal 2007, 6:78 http://www.malariajournal.com/content/6/1/78
Page 10 of 11
(page number not for citation purposes)
Rutherford K, Salzberg SL, Craig A, Kyes S, Chan MS, Nene V, Shal-
lom SJ, Suh B, Peterson J, Angiuoli S, Pertea M, Allen J, Selengut J, Haft
D, Mather MW, Vaidya AB, Martin DMA, Fairlamb AH, Fraunholz MJ,
Roos DS, Ralph SA, McFadden GI, Cummings LM, Subramanian GM,
Mungall C, Venter JC, Carucci DJ, Hoffman SL, Newbold C, Davis
RW, Fraser CM, Barrell B: Genome sequence of the human
malaria parasite Plasmodium falciparum.  Nature 2002,
419:498-511.
11. Lavstsen T, Salanti A, Jensen ATR, Arnot DE, Theander TG: Sub-
grouping of Plasmodium falciparum 3D7 var genes based on
sequence analysis of coding and non-coding regions.  Malaria
Journal 2003, 2:27.
12. Kraemer SM, Smith JD: Evidence for the importance of genetic
structuring to the structural and functional specialization of
the Plasmodium falciparum var gene family.  Mol Microbiol 2003,
50:1527-1538.
13. Marsh K, Otoo L, Hayes RJ, Carson DC, Greenwood BM: Antibod-
ies to blood stage antigens of Plasmodium falciparum in rural
Gambians and their relation to protection against infection.
Trans R Soc Trop Med Hyg 1989, 83:293-303.
14. Bull PC, Lowe BS, Kortok M, Molyneux CS, Newbold CI, Marsh K:
Parasite antigens on the infected red cell surface are targets
for naturally acquired immunity to malaria.  Nat Med 1998,
4:358-360.
15. Ofori MF, Dodoo D, Staalsoe T, Kurtzhals JAL, Koram K, Theander
TG, Akanmori BD, Hviid L: Malaria-induced acquisition of anti-
bodies to Plasmodium falciparum variant surface antigens.
Infect Immun 2002, 70:2982-2988.
16. Duffy PE, Fried M: Antibodies that inhibit Plasmodium falci-
parum adhesion to chondroitin sulfate A are associated with
increased birth weight and the gestational age of Newborns.
Infect Immun 2003, 71:6620-6623.
17. Staalsoe T, Shulman CE, Bulmer JN, Kawuondo K, Marsh K, Hviid L:
Variant surface antigen-specific IgG and protection against
clinical consequences of pregnancy-associated Plasmodium
falciparum malaria.  Lancet 2004, 363:283-289.
18. Salanti A, Staalsoe T, Lavstsen T, Jensen ATR, Sowa MPK, Arnot DE,
Hviid L, Theander TG: Selective upregulation of a single dis-
tinctly structured var gene in chondroitin sulphate A-adher-
ing Plasmodium falciparum involved in pregnancy-associated
malaria.  Mol Microbiol 2003, 49:179-191.
19. Salanti A, Dahlback M, Turner L, Nielsen MA, Barfod L, Magistrado P,
Jensen ATR, Lavstsen T, Ofori MF, Marsh K, Hviid L, Theander TG:
Evidence for the involvement of VAR2CSA in pregnancy-
associated malaria.  J Exp Med 2004, 200:1197-1203.
20. Jensen ATR, Magistrado P, Sharp S, Joergensen L, Lavstsen T, Chiuc-
ciuini A, Salanti A, Vestergaard LS, Lusingu JP, Hermsen R, Sauerwein
R, Christensen J, Nielsen MA, Hviid L, Sutherland C, Staalsoe T, The-
ander TG: Plasmodium falciparum associated with severe child-
hood malaria preferentially expresses PfEMP1 encoded by
group A var  genes.  Journal of Experimental Medicine 2004,
199:1179-1190.
21. Magistrado PA, Lusingu J, Vestergaard LS, Lemnge M, Lavstsen T,
Turner L, Hviid L, Jensen AT, Theander TG: IgG antibody reactiv-
ity to a Group A PfEMP1 and protection from Plasmodium
falciparum malaria.  Infect Immun 2007, 75:2415-2420.
22. Scherf A, Hernandez-Rivas R, Buffet P, Bottius E, Benatar C, Pouvelle
B, Gysin J, Lanzer M: Antigenic variation in malaria: in situ
switching, relaxed and mutually exclusive transcription of
var genes during intra-erythrocytic development in Plasmo-
dium falciparum.  EMBO J 1998, 17:5418-5426.
23. Chen QJ, Fernandez V, Sundstrom A, Schlichtherle M, Datta S, Hagb-
lom P, Wahlgren M: Developmental selection of var  gene
expression in Plasmodium falciparum.  Nature 1998,
394:392-395.
24. Kyes S, Pinches R, Newbold C: A simple RNA analysismethod
shows var and rif multigene family expression patterns in
Plasmodium falciparum.  Mol Biochem Parasitol 2000, 105:311-315.
25. Kyes SA, Christodoulou Z, Raza A, Horrocks P, Pinches R, Rowe JA,
Newbold CI: A well-conserved Plasmodium falciparum var gene
shows an unusual stage-specific transcript pattern.  Mol Micro-
biol 2003, 48:1339-1348.
26. Noviyanti R, Brown GV, Wickham ME, Duffy MF, Cowman AF,
Reeder JC: Multiple var gene transcripts are expressed in Plas-
modium falciparum infected erythrocytes selected for adhe-
sion.  Mol Biochem Parasitol 2001, 114:227-237.
27. Duffy MF, Brown GV, Basuki W, Krejany EO, Noviyanti R, Cowman
AF, Reeder JC: Transcription of multiple var genes by individ-
ual, trophozoite-stage Plasmodium falciparum cells express-
ing a chondroitin sulphate A binding phenotype.  Mol Microbiol
2002, 43:1285-1293.
28. Trager W, Jensen JB: Human malaria parasites in continuous
culture.  Science 1976, 193:673-675.
29. Staalsoe T, Giha HA, Dodoo D, Theander TG, Hviid L: Detection of
antibodies to variant antigens on Plasmodium falciparum-
infected erythrocytes by flow cytometry.  Cytometry 1999,
35:329-336.
30. Ricke CH, Staalsoe T, Koram K, Akanmori BD, Riley EM, Theander
TG, Hviid L: Plasma antibodies from malaria-exposed preg-
nant women recognize variant surface antigens on Plasmo-
dium falciparum -infected erythrocytes in a parity-dependent
manner and block parasite adhesion to chondroitin sulfate
A.  J Immunol 2000, 165:3309-3316.
31. Paul F, Roath S, Melville D, Warhurst DC, Osisanya JO: Separation
of malaria-infected erythrocytes from whole blood: use of a
selective high-gradient magnetic separation technique.  Lan-
cet 1981, 2:70-71.
32. PlasmoDB – The Plasmodium Genome Resource   [http://
www.plasmodb.org]
33. Dzikowski R, Frank M, Deitsch K: Mutually exclusive expression
of virulence genes by malaria parasites is regulated inde-
pendently of antigen production.  PLoS Pathog 2006, 2:e22.
34. Voss TS, Healer J, Marty AJ, Duffy MF, Thompson JK, Beeson JG,
Reeder JC, Crabb BS, Cowman AF: A var gene promoter controls
allelic exclusion of virulence genes in Plasmodium falciparum
malaria.  Nature 2006, 439:1004-1008.
35. Dembo EG, Phiri HT, Montgomery J, Molyneux ME, Rogerson SJ: Are
Plasmodium falciparum parasites present in peripheral blood
genetically the same as those sequestered in the tissues?  Am
J Trop Med Hyg 2006, 74:730-732.
36. Taylor HM, Kyes SA, Harris D, Kriek N, Newbold CI: A study of var
gene transcription in vitro using universal var gene primers.
Mol Biochem Parasitol 2000, 105:13-23.
37. Kyes S, Christodoulou Z, Pinches R, Kriek N, Horrocks P, Newbold
C: Plasmodium falciparum var gene expression is developmen-
tally controlled at the level of RNA polymerase II-mediated
transcription initiation.  Mol Microbiol 2007, 63:1237-1247.
38. Duffy MF, Byrne TJ, Elliott SR, Wilson DW, Rogerson SJ, Beeson JG,
Noviyanti R, Brown GV: Broad analysis reveals a consistent pat-
tern of var  gene transcription in Plasmodium falciparum
repeatedly selected for a defined adhesion phenotype.  Mol
Microbiol 2005, 56:774-788.
39. Duraisingh MT, Voss TS, Marty AJ, Duffy MF, Good RT, Thompson
JK, Freitas-Junior LH, Scherf A, Crabb BS, Cowman AF: Hetero-
chromatin silencing and locus repositioning linked to regula-
tion of virulence genes in Plasmodium faiciparum.  Cell 2005,
121:13-24.
40. Ralph SA, Scheidig-Benatar C, Scherf A: Antigenic variation in
Plasmodium falciparum is associated with movement of var
loci between subnuclear locations.  Proc Natl Acad Sci USA 2005,
102:5414-5419.
41. Voss TS, Kaestli M, Vogel D, Bopp S, Beck HP: Identification of
nuclear proteins that interact differentially with Plasmodium
falciparum var gene promoters.  Mol Microbiol 2003,
48:1593-1607.
42. Winter G, Chen QJ, Flick K, Kremsner P, Fernandez V, Wahlgren M:
The 3D7var5.2 (var COMMON) type var gene family is com-
monly expressed in non-placental Plasmodium falciparum
malaria.  Mol Biochem Parasitol 2003, 127:179-191.
43. Gannoun-Zaki L, Jost A, Mu JB, Deitsch KW, Wellems TE: A
silenced  Plasmodium falciparum var promoter can be acti-
vated in vivo through spontaneous deletion of a silencing ele-
ment in the intron.  Eukaryot Cell 2005, 4:490-492.
44. Frank M, Dzikowski R, Costantini D, Amulic B, Berdougo E, Deitsch
K: Strict pairing of var promoters and introns is required for
var gene silencing in the malaria parasite Plasmodium falci-
parum.  J Biol Chem 2006, 281:9942-9952.
45. Gardner JP, Pinches RA, Roberts DJ, Newbold CI: Variantantigens
and endothelial receptor adhesion in Plasmodium falciparum.
Proc Natl Acad Sci USA 1996, 93:3503-3508.
46. Waterkeyn JG, Wickham ME, Davern KM, Cooke BM, Coppel RL,
Reeder JC, Culvenor JG, Waller RF, Cowman AF: Targeted muta-Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Malaria Journal 2007, 6:78 http://www.malariajournal.com/content/6/1/78
Page 11 of 11
(page number not for citation purposes)
genesis of Plasmodium falciparum erythrocyte membrane
protein 3 (PfEMP3) disrupts cytoadherence of malaria-
infected red blood cells.  EMBO J 2000, 19:2813-2823.
47. Kriek N, Tilley L, Horrocks P, Pinches R, Elford BC, Ferguson DJP,
Lingelbach K, Newbold CI: Characterization of the pathway for
transport of the cytoadherence-mediating protein, PfEMP1,
to the host cell surface in malaria parasite-infected erythro-
cytes.  Mol Microbiol 2003, 50:1215-1227.